NIBR189

Biochem/physiol Actions

NBIR189 is a high-affinity, potent and selective EBI2 (GPR183) antagonist (IC50 = 16 nM against 10 nM 7A,25-OHC for binding human EBI2) that inhibits 7A,25-OHC-induced GTPγS binding (IC50 = 8.5 and 7.0 nM, respectively, against 0.33 and 0.1 nM OHC; human EBI2-expressing CHO membrane), calcium mobilization (IC50 = 11 and 15 nM using human or mouse EBI2-transfected cells, respectively), and chemotaxis (IC50 = 0.3 nM against 20 nM OHC-induced U937 migration). NBIR189 displays no inhibitory potency against 5HT2A, muscarinic acetylcholine receptor M2, adrenoreceptor A1A, nor significant affintiy toward 18 other GPCRs/transporters/enzymes, and exhibits good pharmacokinetic properties and oral availability in mice (AUC = 3608 nmol h/L, Cmax = 835 nM, tmax = 1 h, F = 49%; 3 mg/kg p.o.). A useful tool for probing EBI2-mediated physiological functions and autoimmune disorders.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3575654 NIBR189 white to beige SIGMA-ALDRICH room temp DMSO: 10 mg/mL, clear (warmed) powder ≥98% (HPLC)
£490.29 (exc VAT) per 25MG
-
+
3575655 NIBR189 white to beige SIGMA-ALDRICH room temp DMSO: 10 mg/mL, clear (warmed) powder ≥98% (HPLC)
£142.07 (exc VAT) per 5MG
-
+